Evaluation of renal tubular function in children taking anti-epileptic treatment

Nephrology

Volumn 11, Issue 6, 2006, Pages 485-488

  Unay, Bulent ^a   Akin, Ridvan ^a   Sarici, S Umit ^a   Gok, Faysal ^a   Kurt, Ismail ^a   Gokcay, Erdal ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Anti epileptic; Carbamazepine; Lamotrigine; N acetyl D glucosaminidase; Renal tubular function; Valproate

Indexed keywords

ANTICONVULSIVE AGENT; BIOLOGICAL MARKER; CARBAMAZEPINE; CREATININE; LAMOTRIGINE; N ACETYL BETA GLUCOSAMINIDASE; UREA; VALPROIC ACID;

ANTICONVULSANT THERAPY; ARTICLE; CHILD; CLINICAL INDICATOR; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; EPILEPSY; FOCAL EPILEPSY; GRAND MAL SEIZURE; HUMAN; KIDNEY TUBULE DISORDER; KIDNEY TUBULE FUNCTION; LONG TERM CARE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; UREA BLOOD LEVEL; URINARY EXCRETION; URINE LEVEL;

ACETYLGLUCOSAMINIDASE; ANTICONVULSANTS; BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; CARBAMAZEPINE; CHILD; CHILD, PRESCHOOL; CREATININE; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; EPILEPSY, GENERALIZED; HUMANS; KIDNEY TUBULES; TRIAZINES; VALPROIC ACID;

EID: 33845667452     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2006.00699.x     Document Type: Article

References (21)

1. Korinthberg R, Wehrle L, Zimmerhackl LB. Renal tubular dysfunction following treatment with antiepileptic drugs. Eur. J. Pediatr. 1994; 153: 855-8.
2. Novo MLP, Izumi T, Yokota K et al. Urinary excretion of N-acetyl-β-D-glucosaminidase and β-galactosidase by patients with epilepsy. Brain Dev. 1993; 15: 157-60.
3. Otsuka T, Sunaga Y, Hikima A. Urinary N-acetyl-β-D-glucosaminidase and guanidinoacetic acid in epileptic patients treated with antiepileptic drugs. Brain Dev. 1994; 16: 437-40.
4. Yüksel A, Cengiz M, Seven M et al. N-acetyl-β-D-glucosaminidase and β-galactosidase activity in children receiving antiepileptic drugs. Pediatr. Neurol. 1999; 20: 24-6.
5. Chiarelli F, La Penna G, Morgese G. Urinary excretion of low moleculer weight proteins in type I diabetic children and adolescents. Pediatr. Adolesc. Endocrinol. 1989; 18: 160-66.
6. Tseng JI, Wang PJ, Tsau YK et al. Urinary N-acetyl-β-D- glucosaminidase in children receiving antiepileptic drugs. Acta Paediatr. 1992; 33: 251-6.
7. Olah AV, Csathy L, Pocsi I, Price RG. Reference ranges for urinary N-acetyl-β-D-glucosaminidase in healthy children determined with three colorimetric methods using PNP-G1cNAc MNP-G1cNAc and VRA-G1cNAc as substrates. Ann. Clin. Biochem. 1994; 31: 77-8.
8. Altunbaşak Ş, Yildizaş D, Anarat A, Burgut HR. Renal tubular dysfunction in epileptic children on valproic acid therapy. Pediatr. Nephrol. 2001; 16: 256-9.
9. Csathy L, Pocsi I. Urinary N-acetyl-β-D-glucosaminidase determination in newborns and children: Methods and diagnostic applications. Eur. J. Clin. Chem. Clin. Biochem. 1995; 33: 575-87.
10. Csathy L, Olah AV, Clemens B et al. Urinary N-acetyl-β-D- glucosaminidase in epileptic children treated with antiepileptic drugs. Arch. Dis. Child 2000; 83: 420-2.
11. Garvey MJ, Noel M. Is carbamazepine associated with NAG elevations suggestive of renal disease? Brain Dev. 1995; 17: 222-4.
12. Verrotti A, Greco R, Pascerella V et al. Renal tubular function in patients receiving anticonvulsant therapy: A long-term study. Epilepsia 2000; 41: 1432-5.
13. Muller PH, Macnell ML, Steinberg KK. Stabilization of alanine aminopeptidase, gamma-glutamyl transpeptidase and N-acetyl-β-D- glucosaminidase activity in normal urine. Arch. Environ. Contam. Toxicol. 1986; 15: 343-7.
14. Balla AA, Salah AM, Abdalmotaal E et al. N-acetyl-β-D- glucosaminidase excretion in healthy children and in pediatric patients with urolithiazis. World J. Urol. 1998; 16: 413-16.
15. Tomlinson PA, Smellie JM, Prescod N et al. Differential excretion of urinary proteins in children with vesicoureteric reflux and reflux nephropathy. Pediatr. Nephrol. 1994; 8: 21-5.
16. Goonasekera CDA, Shah V, Dillon MJ. Tubular proteinuria in reflux nephropathy: Post ureteric re-implantation. Pediatr. Nephrol. 1996; 10: 559-63.
17. Weitgasser R, Schnoell F, Gappmayer B, Kartnig I. Prospective evaluation of urinary N-acetyl-β-D-glucosaminidase with respect to macrovasculer disease in elderly type 2 diabetic patients. Diabetes Care 1999; 22: 1882-6.
18. Belfiore F, Napoli E, Lo Vecchio L, Rabuazzo AM. Increased serum activity of N-acetyl-β-D-glucosaminidase in atherosclerosis. Am. J. Med. Sci. 1974; 268: 235-9.
19. Doval M, Culebras M, Lopez-Farre A et al. Effect of valproate on lactate and glutamine metabolism by rat renal cortical tubules. Proc. Soc. Exp. Biol. Med. 1989; 190: 357-64.
20. Gougoux A, Vinay P. Metabolic effects of valproate on dog renal cortical tubules. Can. J. Physiol. Pharmacol. 1989; 67: 88-97.
21. Hawkins E, Brewer E. Renal toxicity induced by valproic acid (Depakene). Pediatr. Pathol. 1993; 13: 863-8.